WHIPPANY, New Jersey, June 22 [Category: BizPharmaceuticals] -- Bayer USA, an enterprise with core competencies in the life science fields of health care and nutrition, posted the following news:

* * *

Bayer and Iambic collaborate to advance drug discovery with AI

*

* Collaboration focuses on small molecule discovery

* Bayer to leverage Iambic's AI platform to address hard-to-drug targets

* Collaboration w . . .

Click here for more information about our products